TrialRheumatology (Oxford, England)2022

Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial.

Frank Behrens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.